Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Question

I have asked this question several times in the past and I am surprised we have good people here with long experience in penny stock trading none of them have been able to give any answer.

Why is it that since the last share holders meeting BOD and management are not buying this stock as an evidence ptsc is true to it.

One of the key points in the shareholders prospectus was that BOD and management should be giving the free hand to buy ptsc shares in the open market.

Are they hiding something?

Share
New Message
Please login to post a reply